The Bio Terrorist State is actively doing Bio Weapon's research
China’s Wuhan Institute of Virology, where the COVID-19 pandemic may have started, conducted work on a deadlier virus with a 60% lethality rate, according to recent Senate testimony.
Steven Quay, a medical doctor, told the Senate Homeland Security and Governmental Affairs subcommittee on emerging threats that the Wuhan institute carried out synthetic biology research on the Nipah virus genome in December 2019, around the time the first COVID-19 cases surfaced in Wuhan. Scientists are divided over whether the coronavirus that causes COVID-19 emerged naturally through animals or can be traced to a leak or accident at the Wuhan facility.
“The Nipah virus was in an infectious clone format,” Dr. Quay testified. “Nipah is a BSL-4 level pathogen and a CDC-designated bioterrorism agent. This is the most dangerous gain-of-function research I have ever encountered. We should assume this research continues to this day at the WIV.”
If confirmed, China’s research on Nipah could violate the Biological Weapons Convention, which Beijing has signed, that prohibits work on agents that can be used as bioweapons.
Nipah is smaller than the virus behind COVID-19, known as SARS-CoV-2, and is less transmissible.
“But it is one of the deadliest viruses, with a 60% lethality,” said Dr. Quay, chief executive officer of Atossa Therapeutics, a Seattle-based pharmaceutical company.
“This is 60 times deadlier than SARS-2,” he said, using the shortened term for the virus behind COVID-19. “The lab where the human specimens were processed is not the highest-level biosafety lab, BSL-4, but was in the BSL-2 or -3 facility.”
Dr. Quay said he did not know why Chinese researchers were working on the Nipah virus, “but a laboratory-acquired infection with a modified Nipah virus would make the COVID-19 pandemic look like a walk in the park.”
Unlike SARS-CoV-2, Nipah is unable to spread in the air. Still, if the research produced an aerosolized version of the virus, it could cause a deadlier pandemic, Dr. Quay testified.
A Black Death parallel?
In an interview, Dr. Quay said he discovered the Wuhan study on Nipah in Chinese research data mistakenly posted on GenBank, a U.S.-based repository for DNA sequencing information. Mr. Quay said the danger in China’s work on Nipah is that it could become aerosolized and cause mass death.
“The Black Plague in Europe was a 20% lethal event, and it set society back 250 years,” he said. A Nipah pandemic would “set us back over a millennium, in my estimate.”
Spokespeople for the Centers for Disease Control and Prevention, the National Institutes of Health and the Chinese Embassy did not respond to requests for comment.
A State Department spokesman said: “We are aware of the Aug. 3 testimony. We have no comment for your story.”
https://www.washingtontimes.com/news/2022/aug/9/chinas-wuhan-institute-studied-deadly-bioterrorism/
China’s Wuhan Institute of Virology, where the COVID-19 pandemic may have started, conducted work on a deadlier virus with a 60% lethality rate, according to recent Senate testimony.
Steven Quay, a medical doctor, told the Senate Homeland Security and Governmental Affairs subcommittee on emerging threats that the Wuhan institute carried out synthetic biology research on the Nipah virus genome in December 2019, around the time the first COVID-19 cases surfaced in Wuhan. Scientists are divided over whether the coronavirus that causes COVID-19 emerged naturally through animals or can be traced to a leak or accident at the Wuhan facility.
“The Nipah virus was in an infectious clone format,” Dr. Quay testified. “Nipah is a BSL-4 level pathogen and a CDC-designated bioterrorism agent. This is the most dangerous gain-of-function research I have ever encountered. We should assume this research continues to this day at the WIV.”
If confirmed, China’s research on Nipah could violate the Biological Weapons Convention, which Beijing has signed, that prohibits work on agents that can be used as bioweapons.
Nipah is smaller than the virus behind COVID-19, known as SARS-CoV-2, and is less transmissible.
“But it is one of the deadliest viruses, with a 60% lethality,” said Dr. Quay, chief executive officer of Atossa Therapeutics, a Seattle-based pharmaceutical company.
“This is 60 times deadlier than SARS-2,” he said, using the shortened term for the virus behind COVID-19. “The lab where the human specimens were processed is not the highest-level biosafety lab, BSL-4, but was in the BSL-2 or -3 facility.”
Dr. Quay said he did not know why Chinese researchers were working on the Nipah virus, “but a laboratory-acquired infection with a modified Nipah virus would make the COVID-19 pandemic look like a walk in the park.”
Unlike SARS-CoV-2, Nipah is unable to spread in the air. Still, if the research produced an aerosolized version of the virus, it could cause a deadlier pandemic, Dr. Quay testified.
A Black Death parallel?
In an interview, Dr. Quay said he discovered the Wuhan study on Nipah in Chinese research data mistakenly posted on GenBank, a U.S.-based repository for DNA sequencing information. Mr. Quay said the danger in China’s work on Nipah is that it could become aerosolized and cause mass death.
“The Black Plague in Europe was a 20% lethal event, and it set society back 250 years,” he said. A Nipah pandemic would “set us back over a millennium, in my estimate.”
Spokespeople for the Centers for Disease Control and Prevention, the National Institutes of Health and the Chinese Embassy did not respond to requests for comment.
A State Department spokesman said: “We are aware of the Aug. 3 testimony. We have no comment for your story.”
https://www.washingtontimes.com/news/2022/aug/9/chinas-wuhan-institute-studied-deadly-bioterrorism/